Coya Therapeutics, Inc. Common Stock (COYA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.98
• Market Cap: $105.67M
• EPS: $-1.11
• 52-Week High: $8.29
• 52-Week Low: $3.94

Market Sentiment

Coya Therapeutics, Inc. Common Stock currently has a Bullish sentiment score of 0.37.

About Coya Therapeutics, Inc. Common Stock

Coya Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Houston, Texas, dedicated to developing innovative therapies that enhance the effectiveness of regulatory T cells (Tregs) for the treatment of autoimmune and neurodegenerative diseases. With a proprietary platform, Coya is advancing its pipeline towards critical indications such as Multiple Sclerosis and Amyotrophic Lateral Sclerosis, positioning itself as a leader in Treg modulation. As the company progresses ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Coya Therapeutics, Inc. Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does COYA pay dividends?

Coya Therapeutics, Inc. Common Stock (COYA) does not currently pay a regular dividend.

What is COYA's market cap?

Coya Therapeutics, Inc. Common Stock (COYA) has a market capitalization of $105.67M with a current stock price of $4.98.